Kilitch Drugs (India) Limited (KILITCH.BO)
INR 317.75
(-0.87%)
INR 317.75
(-0.87%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -56.68 Million | 25.85 Million | 57.83 Million | 456.58 Million | 44.61 Million | 2.9 Million |
| Net Income | 146.01 Million | 120.14 Million | 96.14 Million | 51.19 Million | 16.07 Million | 85.86 Million |
| Depreciation & Amortization | 33.49 Million | 35.5 Million | 24.65 Million | 19.86 Million | 19.99 Million | 20.51 Million |
| Deferred income taxes | - | - | - | -6.15 Million | -60.05 Million | - |
| Stock-based compensation | - | - | - | -1.57 Million | 668 Thousand | - |
| Change in working capital | -243.12 Million | -148.83 Million | -51.89 Million | 387.52 Million | 63.31 Million | -59.85 Million |
| Other non-cash items | 335.37 Million | 19.04 Million | -11.07 Million | 5.73 Million | 4.61 Million | -43.61 Million |
| Investing Cash Flow | -85.26 Million | 79.15 Million | -152.5 Million | -375.69 Million | -104.54 Million | -139.78 Million |
| Investments in PPE | -64.5 Million | -38.11 Million | -82.01 Million | -362.97 Million | -104.99 Million | -190.21 Million |
| Acquisitions | 14.25 Million | -591 Thousand | 109 Thousand | 955 Thousand | 1.21 Million | - |
| Investment purchases | -35.01 Million | 3.68 Million | -69.25 Million | -16.59 Million | -11.97 Million | - |
| Sales/Maturities of investments | - | 94.33 Million | 2.38 Million | 1.62 Million | 9.69 Million | 46.4 Million |
| Other Investing Activities | -5.41 Million | 19.84 Million | -3.72 Million | 1.3 Million | 1.51 Million | 4.02 Million |
| Financing Cash Flow | 133.1 Million | -7.16 Million | 70.28 Million | 16.14 Million | 8.49 Million | 168.55 Million |
| Debt repayment | -94.52 Million | -17.61 Million | -25 Million | -7.54 Million | -31.55 Million | -85.32 Million |
| Dividends payments | - | - | -11.98 Million | - | -17.9 Million | -9.5 Million |
| Common Stock Repurchased | - | - | 31.28 Million | - | -7.15 Million | 170.65 Million |
| Common Stock Issuance | 38.57 Million | 25 Million | 25.87 Million | 604 Thousand | 790 Thousand | 70.49 Million |
| Other Financing Activities | 14.25 Million | -14.54 Million | 50.1 Million | 23.08 Million | 64.31 Million | 22.23 Million |
| Accounts receivables | -119.17 Million | -154.88 Million | -202.96 Million | -86.64 Million | 55.12 Million | -12.83 Million |
| Accounts payables | -122.85 Million | -19.94 Million | 227.15 Million | 465.6 Million | 28.48 Million | -31.94 Million |
| Inventory | -19.43 Million | 29.55 Million | -14.14 Million | 19.7 Million | -8.4 Million | -19.19 Million |
| Other working capital | 18.33 Million | -3.56 Million | -61.93 Million | -11.14 Million | -11.88 Million | 4.11 Million |
| Cash at beginning of period | 198.46 Million | 100.61 Million | 125 Million | 27.96 Million | 79.4 Million | 47.72 Million |
| Cash at end of period | 196.42 Million | 198.46 Million | 100.61 Million | 125 Million | 27.96 Million | 79.4 Million |
| Capital Expenditure | -64.5 Million | -38.11 Million | -82.01 Million | -362.97 Million | -104.99 Million | -190.21 Million |
| Effect of forex changes on cash | - | - | 1000.00 | - | - | -1000.00 |
| Net cash flow / Change in cash | -2.03 Million | 97.84 Million | -24.39 Million | 97.03 Million | -51.43 Million | 31.67 Million |
| Free Cash Flow | -121.18 Million | -12.26 Million | -24.18 Million | 93.61 Million | -60.38 Million | -187.3 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 146.01 Million | 29.09 Million | 47.41 Million | 33.57 Million | 120.14 Million | 35.63 Million |
| Depreciation & Amortization | 33.49 Million | 8.14 Million | 8.16 Million | 7.89 Million | 35.5 Million | 9.14 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -243.12 Million | - | - | - | -148.83 Million | - |
| Other non-cash items | 335.37 Million | -8.14 Million | -8.16 Million | -7.89 Million | 19.04 Million | -9.14 Million |
| Investing Cash Flow | -85.26 Million | - | - | - | 79.15 Million | - |
| Investments in PPE | -64.5 Million | - | - | - | -38.11 Million | - |
| Acquisitions | 14.25 Million | - | - | - | -591 Thousand | - |
| Investment purchases | -35.01 Million | - | - | - | 3.68 Million | - |
| Sales/Maturities of investments | - | - | - | - | 94.33 Million | - |
| Other Investing Activities | -5.41 Million | - | - | - | 19.84 Million | - |
| Financing Cash Flow | 133.1 Million | - | - | - | -7.16 Million | - |
| Debt repayment | -94.52 Million | - | - | - | -17.61 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 38.57 Million | - | - | - | 25 Million | - |
| Other Financing Activities | 14.25 Million | - | - | - | -14.54 Million | - |
| Accounts receivables | -119.17 Million | - | - | - | -154.88 Million | - |
| Accounts payables | -122.85 Million | - | - | - | -19.94 Million | - |
| Inventory | -19.43 Million | - | - | - | 29.55 Million | - |
| Other working capital | 18.33 Million | - | - | - | -3.56 Million | - |
| Cash at beginning of period | 198.46 Million | 93.66 Million | 46.25 Million | 198.46 Million | 100.61 Million | 162.82 Million |
| Cash at end of period | 196.42 Million | 29.09 Million | 93.66 Million | 33.57 Million | 198.46 Million | 198.46 Million |
| Capital Expenditure | -64.5 Million | - | - | - | -38.11 Million | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -2.03 Million | -64.57 Million | 47.41 Million | -164.88 Million | 97.84 Million | 35.63 Million |
| Free Cash Flow | -121.18 Million | 29.09 Million | 47.41 Million | 33.57 Million | -12.26 Million | 35.63 Million |
BUVA
POR
300244
SYNT
300033
301188